Literature DB >> 17035489

Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease.

Kathryn L Jones1, Lisa J Glickstein, Nitin Damle, Vijay K Sikand, Gail McHugh, Allen C Steere.   

Abstract

Three genetic markers of Borrelia burgdorferi have been associated with disseminated disease: the OspC type, the 16S-23S rRNA intergenic spacer type (RST), and vlsE. Here, we modified previous methods so as to identify the three markers by PCR and restriction fragment length polymorphism in parallel, analyzed B. burgdorferi isolates from erythema migrans (EM) skin lesions in 91 patients, and correlated the results with evidence of dissemination. OspC type A was found approximately twice as frequently in patients with disseminated disease, whereas type K was identified approximately twice as often in those without evidence of dissemination, but these trends were not statistically significant. The remaining seven types identified were found nearly equally in patients with or without evidence of dissemination. RST 1 strains were significantly associated with dissemination (P=0.03), whereas RST 2 and RST 3 strains tended to have an inverse association with this outcome. The vlsE gene was identified in all 91 cases, using primer sets specific for an N-terminal sequence of B. burgdorferi strain B31 (vlsEB31) or strain 297 (vlsE297), but neither marker was associated with dissemination. Specific combinations of the three genetic markers usually occurred together. OspC type A was always found with RST 1 and vlsEB31, type K was always identified with RST 2 and more often with vlsE297, and types E and I were almost always found with RST 3 and equally often with vlsEB31 and vlsE297. We conclude that B. burgdorferi strains vary in their capacity to disseminate, but almost all strains isolated from EM lesions sometimes caused disseminated disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035489      PMCID: PMC1698394          DOI: 10.1128/JCM.01077-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

Review 1.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

2.  Yield of large-volume blood cultures in patients with early Lyme disease.

Authors:  G P Wormser; S Bittker; D Cooper; J Nowakowski; R B Nadelman; C Pavia
Journal:  J Infect Dis       Date:  2001-08-29       Impact factor: 5.226

3.  Correlation between plasmid content and infectivity in Borrelia burgdorferi.

Authors:  J E Purser; S J Norris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice.

Authors:  G Wang; C Ojaimi; R Iyer; V Saksenberg; S A McClain; G P Wormser; I Schwartz
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  Infection with multiple strains of Borrelia burgdorferi sensu stricto in patients with Lyme disease.

Authors:  G Seinost; W T Golde; B W Berger; J J Dunn; D Qiu; D S Dunkin; D E Dykhuizen; B J Luft; R J Dattwyler
Journal:  Arch Dermatol       Date:  1999-11

6.  Conservation and heterogeneity of vlsE among human and tick isolates of Borrelia burgdorferi.

Authors:  R Iyer; J M Hardham; G P Wormser; I Schwartz; S J Norris
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-1.

Authors:  M Labandeira-Rey; J T Skare
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

8.  Cellular and humoral immune responses to Borrelia burgdorferi antigens in patients with culture-positive early Lyme disease.

Authors:  A Vaz; L Glickstein; J A Field; G McHugh; V K Sikand; N Damle; A C Steere
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis.

Authors:  D Liveris; A Gazumyan; I Schwartz
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes.

Authors:  John V McDowell; Shian-Ying Sung; Linden T Hu; Richard T Marconi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more
  48 in total

1.  Geographic variation in the relationship between human Lyme disease incidence and density of infected host-seeking Ixodes scapularis nymphs in the Eastern United States.

Authors:  Kim M Pepin; Rebecca J Eisen; Paul S Mead; Joseph Piesman; Durland Fish; Anne G Hoen; Alan G Barbour; Sarah Hamer; Maria A Diuk-Wasser
Journal:  Am J Trop Med Hyg       Date:  2012-06       Impact factor: 2.345

2.  Blood treatment of Lyme borreliae demonstrates the mechanism of CspZ-mediated complement evasion to promote systemic infection in vertebrate hosts.

Authors:  Ashley L Marcinkiewicz; Alan P Dupuis; Maxime Zamba-Campero; Nancy Nowak; Peter Kraiczy; Sanjay Ram; Laura D Kramer; Yi-Pin Lin
Journal:  Cell Microbiol       Date:  2019-01-07       Impact factor: 3.715

3.  Analysis of Borrelia burgdorferi genotypes in patients with Lyme arthritis: High frequency of ribosomal RNA intergenic spacer type 1 strains in antibiotic-refractory arthritis.

Authors:  Kathryn L Jones; Gail A McHugh; Lisa J Glickstein; Allen C Steere
Journal:  Arthritis Rheum       Date:  2009-07

4.  The rare ospC allele L of Borrelia burgdorferi sensu stricto, commonly found among samples collected in a coastal plain area of the southeastern United States, is associated with ixodes affinis ticks and local rodent hosts Peromyscus gossypinus and Sigmodon hispidus.

Authors:  Nataliia Rudenko; Maryna Golovchenko; Libor Grubhoffer; James H Oliver
Journal:  Appl Environ Microbiol       Date:  2012-12-07       Impact factor: 4.792

5.  Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii.

Authors:  Klemen Strle; Elise E Drouin; Shiqian Shen; Joseph El Khoury; Gail McHugh; Eva Ruzic-Sabljic; Franc Strle; Allen C Steere
Journal:  J Infect Dis       Date:  2009-12-15       Impact factor: 5.226

6.  Active and passive surveillance and phylogenetic analysis of Borrelia burgdorferi elucidate the process of Lyme disease risk emergence in Canada.

Authors:  Nicholas H Ogden; Catherine Bouchard; Klaus Kurtenbach; Gabriele Margos; L Robbin Lindsay; Louise Trudel; Soulyvane Nguon; François Milord
Journal:  Environ Health Perspect       Date:  2010-03-25       Impact factor: 9.031

7.  Differentiation of reinfection from relapse in recurrent Lyme disease.

Authors:  Robert B Nadelman; Klára Hanincová; Priyanka Mukherjee; Dionysios Liveris; John Nowakowski; Donna McKenna; Dustin Brisson; Denise Cooper; Susan Bittker; Gul Madison; Diane Holmgren; Ira Schwartz; Gary P Wormser
Journal:  N Engl J Med       Date:  2012-11-15       Impact factor: 91.245

8.  Comparative analysis of the properties and ligand binding characteristics of CspZ, a factor H binding protein, derived from Borrelia burgdorferi isolates of human origin.

Authors:  Elizabeth A Rogers; Shane V Abdunnur; John V McDowell; Richard T Marconi
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

9.  Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease.

Authors:  Gary P Wormser; Dustin Brisson; Dionysios Liveris; Klára Hanincová; Sabina Sandigursky; John Nowakowski; Robert B Nadelman; Sara Ludin; Ira Schwartz
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

10.  Wide distribution of a high-virulence Borrelia burgdorferi clone in Europe and North America.

Authors:  Wei-Gang Qiu; John F Bruno; William D McCaig; Yun Xu; Ian Livey; Martin E Schriefer; Benjamin J Luft
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.